Commonwealth Equity Services’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,336
| Closed | -$32K | – | 4193 |
|
|
2024
Q3 | $32K | Hold |
1,336
| – | – | ﹤0.01% | 3973 |
|
|
2024
Q2 | $56K | Sell |
1,336
-150
| -10% | -$7.86K | ﹤0.01% | 3878 |
|
|
2024
Q1 | $96K | Sell |
1,486
-117
| -7% | -$5.93K | ﹤0.01% | 3803 |
|
|
2023
Q4 | $72K | Sell |
1,603
-230
| -13% | -$10.5K | ﹤0.01% | 3720 |
|
|
2023
Q3 | $80K | Hold |
1,833
| – | – | ﹤0.01% | 3604 |
|
|
2023
Q2 | $133K | Hold |
1,833
| – | – | ﹤0.01% | 3522 |
|
|
2023
Q1 | $139K | Hold |
1,833
| – | – | ﹤0.01% | 3428 |
|
|
2022
Q4 | $176K | Hold |
1,833
| – | – | ﹤0.01% | 3278 |
|
|
2022
Q3 | $206K | Buy |
1,833
+77
| +4% | +$8.96K | ﹤0.01% | 3144 |
|
|
2022
Q2 | $222K | Sell |
1,756
-209
| -11% | -$18.4K | ﹤0.01% | 3109 |
|
|
2022
Q1 | $137K | Buy |
1,965
+78
| +4% | +$5.42K | ﹤0.01% | 3424 |
|
|
2021
Q4 | $135K | Hold |
1,887
| – | – | ﹤0.01% | 3392 |
|
|
2021
Q3 | $98K | Hold |
1,887
| – | – | ﹤0.01% | 3427 |
|
|
2021
Q2 | $116K | Buy |
1,887
+93
| +5% | +$5.22K | ﹤0.01% | 3377 |
|
|
2021
Q1 | $132K | Hold |
1,794
| – | – | ﹤0.01% | 3228 |
|
|
2020
Q4 | $164K | Buy |
1,794
+100
| +6% | +$8.38K | ﹤0.01% | 2972 |
|
|
2020
Q3 | $58K | Sell |
1,694
-100
| -6% | -$2.4K | ﹤0.01% | 2936 |
|
|
2020
Q2 | $25K | Hold |
1,794
| – | – | ﹤0.01% | 2900 |
|
|
2020
Q1 | $33K | Hold |
1,794
| – | – | ﹤0.01% | 2717 |
|
|
2019
Q4 | $35K | Buy |
1,794
+166
| +10% | +$3.25K | ﹤0.01% | 2828 |
|
|
2019
Q3 | $31K | Hold |
1,628
| – | – | ﹤0.01% | 2773 |
|
|
2019
Q2 | $34K | Buy |
1,628
+200
| +14% | +$5.89K | ﹤0.01% | 2719 |
|
|
2019
Q1 | $42K | Buy |
1,428
+107
| +8% | +$3.29K | ﹤0.01% | 2670 |
|
|
2018
Q4 | $41K | Hold |
1,321
| – | – | ﹤0.01% | 2580 |
|
|
2018
Q3 | $39K | Hold |
1,321
| – | – | ﹤0.01% | 2708 |
|
|
2018
Q2 | $43K | Buy |
1,321
+321
| +32% | +$10.6K | ﹤0.01% | 2672 |
|
|
2018
Q1 | $29K | Hold |
1,000
| – | – | ﹤0.01% | 2632 |
|
|
2017
Q4 | $22K | Sell |
1,000
-100
| -9% | -$2.19K | ﹤0.01% | 2628 |
|
|
2017
Q3 | $24K | Hold |
1,100
| – | – | ﹤0.01% | 2513 |
|
|
2017
Q2 | $23K | Sell |
1,100
-650
| -37% | -$13K | ﹤0.01% | 2472 |
|
|
2017
Q1 | $40K | Hold |
1,750
| – | – | ﹤0.01% | 2337 |
|
|
2016
Q4 | $35K | Buy |
1,750
+100
| +6% | +$2.02K | ﹤0.01% | 2257 |
|
|
2016
Q3 | $33K | Hold |
1,650
| – | – | ﹤0.01% | 2190 |
|
|
2016
Q2 | $22K | Hold |
1,650
| – | – | ﹤0.01% | 2197 |
|
|
2016
Q1 | $23K | Hold |
1,650
| – | – | ﹤0.01% | 2165 |
|
|
2015
Q4 | $25K | Hold |
1,650
| – | – | ﹤0.01% | 2142 |
|
|
2015
Q3 | $26K | Sell |
1,650
-281
| -15% | -$4.21K | ﹤0.01% | 2097 |
|
|
2015
Q2 | $26K | Hold |
1,931
| – | – | ﹤0.01% | 2158 |
|
|
2015
Q1 | $25K | Hold |
1,931
| – | – | ﹤0.01% | 2149 |
|
|
2014
Q4 | $28K | Hold |
1,931
| – | – | ﹤0.01% | 2057 |
|
|
2014
Q3 | $27K | Hold |
1,931
| – | – | ﹤0.01% | 2040 |
|
|
2014
Q2 | $33K | Hold |
1,931
| – | – | ﹤0.01% | 2009 |
|
|
2014
Q1 | $39K | Hold |
1,931
| – | – | ﹤0.01% | 1953 |
|
|
2013
Q4 | $31K | Sell |
1,931
-600
| -24% | -$10.8K | ﹤0.01% | 1896 |
|
|
2013
Q3 | $48K | Hold |
2,531
| – | – | ﹤0.01% | 1806 |
|
|
2013
Q2 | $39K | Buy |
+2,531
| New | +$39.4K | ﹤0.01% | 1751 |
|
Other funds holding PRPH
SSWM
PCM
CD
WAM
Commonwealth Equity Services's PRPH Position: Q4 2024 in Review
Commonwealth Equity Services sold out of ProPhase Labs (PRPH) in Q4 2024, closing a stake of 1,336 shares — an estimated $32K sold.
Commonwealth Equity Services first reported a position in PRPH in Q2 2013 and held it in 46 quarters. The position peaked at $222K in Q2 2022. 30 funds tracked by Wall St. Rank hold PRPH as of Q4 2024.
- Commonwealth Equity Services reported no remaining ProPhase Labs position as of Q4 2024 after selling out during the quarter.
- Commonwealth Equity Services sold 1,336 ProPhase Labs shares in Q4 2024, an estimated $32K.
- Commonwealth Equity Services first reported a position in ProPhase Labs in Q2 2013 and held it in 46 quarters.
- Commonwealth Equity Services's ProPhase Labs position peaked at $222K in Q2 2022.
- 30 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2024.
Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.